# PYRIDOSTIGMINE BROMIDE
> **ANDA211694** · Abbreviated New Drug Application (Generic) · Sponsor: NOVITIUM PHARMA · Approved 2019-03-08
## Drug
- **FDA Application Number:** ANDA211694
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PYRIDOSTIGMINE BROMIDE
- **Generic name:** PYRIDOSTIGMINE BROMIDE ORAL
- **Active ingredients:** PYRIDOSTIGMINE BROMIDE
- **Dosage form:** SYRUP
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** NOVITIUM PHARMA
- **Manufacturer:** Novitium Pharma LLC
- **First approval:** 2019-03-08
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211694)
---
*AI Analytics · CC0 1.0*